Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

Researchers have distinguished the nerve cells in the brain that control the beneficial effects of GLP-1R agonists – such as ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Pharmaceutical Executive: What are the factors that are impacting the compounded semaglutide market? Ferrin Williams, PharmD: ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...